Artesunate and its metabolite DHA are both active against the blood-stage asexual parasites and gametocytes of Plasmodium species including the chloroquine resistant strains. Artesunate for Injection ...
The FDA has approved Artesunate for Injection (Amivas) for the initial treatment of severe malaria in adult and pediatric patients. The Food and Drug Administration (FDA) has approved Artesunate for ...
The largest ever clinical trial in patients hospitalized with severe malaria has concluded that the drug artesunate should now be the preferred treatment for the disease in both children and adults ...
Fatality from malaria is still a global problem and could mean that more than a million lives are lost annually to severe malaria and complicated malaria around the world. This is especially possible ...
In March, the U.S. Army Medical Materiel Development Activity, along with its industry partner Amivas LLC, announced the U.S. release of Artesunate for Injection, a drug solution used in the initial ...
Sinopharm Ghana Limited, a leading pharmaceutical company in the country has launched a new product known as Artesunate for Injection into Ghana's competitive pharmaceutical industry. The Marketing ...
NAIROBI, Oct. 13 (Xinhua) -- Kenya's battle against malaria has gained new momentum through the widespread deployment of an injectable drug manufactured by the Chinese pharmaceutical company, Fosun ...
BHUBANESWAR: The State Drug Control Administration on Monday ordered withdrawal of a whole batch of artesunate injection supplied to Government hospitals by the Odisha State Medical Corporation (OSMC) ...
Artesunate and its metabolite DHA are both active against the blood-stage asexual parasites and gametocytes of Plasmodium species including the chloroquine resistant strains. Artesunate for Injection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results